CHIARAMONTE, RAFFAELLA
 Distribuzione geografica
Continente #
EU - Europa 14.327
NA - Nord America 6.466
AS - Asia 4.324
SA - Sud America 292
AF - Africa 61
OC - Oceania 46
Continente sconosciuto - Info sul continente non disponibili 4
Totale 25.520
Nazione #
US - Stati Uniti d'America 6.274
GB - Regno Unito 5.261
DE - Germania 4.757
CN - Cina 2.084
IT - Italia 1.696
SG - Singapore 981
SE - Svezia 750
RU - Federazione Russa 398
IN - India 312
FR - Francia 272
IE - Irlanda 236
BR - Brasile 229
KR - Corea 221
UA - Ucraina 216
DK - Danimarca 175
CA - Canada 174
TR - Turchia 164
HK - Hong Kong 161
FI - Finlandia 159
ID - Indonesia 118
NL - Olanda 118
EU - Europa 81
JP - Giappone 65
BE - Belgio 64
AU - Australia 43
TW - Taiwan 40
CO - Colombia 37
EG - Egitto 35
IR - Iran 34
AT - Austria 31
CH - Svizzera 31
GR - Grecia 28
RO - Romania 27
PH - Filippine 25
VN - Vietnam 23
PL - Polonia 21
ES - Italia 20
NO - Norvegia 16
CZ - Repubblica Ceca 15
TH - Thailandia 11
MX - Messico 10
HU - Ungheria 9
IQ - Iraq 9
PK - Pakistan 9
AE - Emirati Arabi Uniti 8
AR - Argentina 8
IL - Israele 7
JO - Giordania 7
SC - Seychelles 7
HR - Croazia 6
UZ - Uzbekistan 6
AZ - Azerbaigian 5
EC - Ecuador 5
ZA - Sudafrica 5
BD - Bangladesh 4
BG - Bulgaria 4
KG - Kirghizistan 4
MA - Marocco 4
NP - Nepal 4
PT - Portogallo 4
VE - Venezuela 4
AL - Albania 3
LK - Sri Lanka 3
LT - Lituania 3
LU - Lussemburgo 3
NZ - Nuova Zelanda 3
PY - Paraguay 3
SA - Arabia Saudita 3
BN - Brunei Darussalam 2
BZ - Belize 2
CI - Costa d'Avorio 2
CL - Cile 2
KE - Kenya 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
MO - Macao, regione amministrativa speciale della Cina 2
MY - Malesia 2
AM - Armenia 1
AO - Angola 1
BO - Bolivia 1
CR - Costa Rica 1
CU - Cuba 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
FK - Isole Falkland (Malvinas) 1
HN - Honduras 1
LB - Libano 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
MN - Mongolia 1
MU - Mauritius 1
NG - Nigeria 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PR - Porto Rico 1
PS - Palestinian Territory 1
QA - Qatar 1
RS - Serbia 1
Totale 25.594
Città #
Southend 4.992
Frankfurt am Main 3.174
Milan 711
Hanover 687
Singapore 673
Chandler 589
Ashburn 426
Beijing 359
Dearborn 346
Wilmington 335
Seattle 328
Fairfield 311
Ann Arbor 307
Princeton 298
Council Bluffs 240
Dublin 233
Woodbridge 199
Houston 176
Nanjing 169
Cambridge 149
Santa Clara 144
Grafing 129
Jacksonville 128
Mountain View 124
Hong Kong 117
Bengaluru 113
Toronto 106
Jinan 105
Des Moines 104
Shanghai 100
Boardman 98
Redmond 94
Jakarta 90
Helsinki 87
New York 87
Chaoyang 81
Serra 77
Guangzhou 73
Shenyang 73
Redwood City 66
Nanchang 65
Phoenix 64
Brussels 58
Hangzhou 55
Hebei 51
Medford 51
Changsha 46
Sakarya 46
Munich 45
Zhengzhou 45
Andover 42
Los Angeles 42
Istanbul 41
Tianjin 38
Berlin 36
Ottawa 36
Rome 36
Fuzhou 35
San Diego 35
Somerville 34
Bogotá 32
Fremont 32
Eitensheim 29
London 28
Ningbo 25
Nuremberg 24
Wuhan 24
Chicago 23
Jiaxing 22
Nürnberg 22
Kiez 21
Naples 20
Athens 19
Mumbai 19
Taizhou 19
Xian 19
Bitonto 18
Predappio 18
San Jose 18
Seoul 18
São Paulo 18
Tokyo 18
Central 17
Chengdu 17
Costa Mesa 17
Yubileyny 17
Falls Church 16
Kunming 16
Lanzhou 16
Vienna 16
Bühl 15
Cairo 15
Serio 15
Amsterdam 14
Pune 14
Taichung 14
Warsaw 14
Auburn Hills 13
Haikou 13
Quezon City 13
Totale 18.357
Nome #
Multiple myeloma exploits Jagged1 and Jagged2 to promote intrinsic and bone marrow-dependent drug resistance 563
Cancer testis antigen Sperm Protein 17 as a new target for triple negative breast cancer immunotherapy 416
A wide role for NOTCH1 signaling in acute leukemia 353
Notch regola recettori chemochinici che influenzano migrazione e proliferazione nella leucemia linfoblastica acuta a cellule T 346
Oxidative stress signalling in the apoptosis of Jurkat T lymphocytes 334
Extracellular vesicles enhance multiple myeloma metastatic dissemination 324
Cancer Cells Exploit Notch Signaling to Redefine a Supportive Cytokine Milieu 304
Notch signaling deregulation in multiple myeloma : a rational molecular target 303
Notch signaling promotes drug resistance in multiple myeloma through the regulation of the CXCR4/SDF1α axis 290
Extracellular vesicles mediate the communication between multiple myeloma and bone marrow microenvironment in a NOTCH dependent way 277
The impact of sex on ropporin expression in multiple myeloma patients 276
Jagged blockade promotes tumor cells response to Bortezomib in a zebrafish model of multiple myeloma 272
Re-establishing apoptosis competence in bone associated cancers via communicative reprogramming induced through notch signaling inhibition 267
Notch signalling in cancer 266
Notch signaling drives multiple myeloma induced osteoclastogenesis 260
A new strategy of selective Notch receptor targeting in multiple myeloma based on small molecules 259
Multiple myeloma-derived Jagged ligands increases autocrine and paracrine interleukin-6 expression in bone marrow niche 246
Notch1 produce una deregolazione dell’asse chemiochinico CXCR4/SDF1 nelle cellule di mieloma multiplo 241
Inflammatory role of extracellular sphingolipids in Cystic Fibrosis 239
Homotypic and Heterotypic Activation of the Notch Pathway in Multiple Myeloma-Enhanced Angiogenesis: A Novel Therapeutic Target? 237
Allele frequency of two intragenic microsatellite loci of SEL1L gene in Northern Italy population 232
Anti-Notch treatment prevents multiple myeloma cells localization to the bone marrow via the chemokine system CXCR4/SDF-1 231
Targeting Notch to induce anakoinosis in multiple myeloma niche 230
Expression Pattern and Biological Significance of the lncRNA ST3GAL6-AS1 in Multiple Myeloma 229
Long non-coding RNA NEAT1 targeting impairs the DNA repair machinery and triggers anti-tumor activity in multiple myeloma 225
Targeting tumor initiating cells through inhibition of cancer testis antigens and notch signaling : A hypothesis 222
HEBE project: Healthy aging versus inflamm-aging: The role of physical exercise in modulating the biomarkers of age-associated and environmentally determined chronic diseases, study protocol 219
Jagged1/2 inhibition promotes multiple myeloma cell sensitivity to Bortezomib in vitro, ex-vivo and in vivo in a novel zebrafish model 218
Jagged1/2 inhibition promotes tumor cells response to Bortezomib in a zebrafish model of multiple myeloma 217
The Notch pathway in tumor cell migration 215
Molecular events underlying interleukin-6 independence in a subclone of the CMA-03 multiple myeloma cell line 209
Identification of small molecules uncoupling the Notch : Jagged interaction through an integrated high-throughput screening 207
Reciprocal regulation of Notch and PI3K/Akt signalling in T-ALL cells in vitro 205
Notch signaling promotes bone marrow-induced drug resistance in multiple myeloma through the regulation of the CXCR4/CXCL12 system 205
AKT regulation of oncogenic Notch pathway in T-cell acute lymphoblastic leukemia 204
Notch-targeted therapeutic strategy in multiple myeloma based on small molecules hampering receptor-ligand interaction 204
AKT promotes the oncogenic Notch signaling in T-cell acute lymphoblastic leukemia 203
A new therapeutic strategy in multiple myeloma based on small molecules directed to notch pathway 203
Notch1 produces a deregulation of CXCR4/SDF1 chemokine signaling in Multiple Myeloma cells 200
Targeting notch as a therapeutic approach for human malignancies 200
Notch-directed microenvironment reprogramming in myeloma : a single path to multiple outcomes 196
Is Notch1 involved in the deregulation of molecular processes in T-ALL? 192
Rational for molecular targeting the communication of multiple myeloma and bone marrow niche : why Notch? 192
The role of notch pathway in multiple myeloma progression toward IL-6 independence 192
The Notch pathway controls multiple myeloma crosstalk with the osteoclastogenic niche 191
Understanding the role of extracellular vesicles in the interaction of multiple myeloma with the surrounding microenvironment: the key contribution of the Notch pathway 190
Resveratrol dependent apoptosis in T-acute lymphoblastic leukemia cell line MOLT-4 188
Bone marrow-mediated drug resistance is promoted by Jagged-induced notch pathway in multiple myeloma 188
The role of Notch in apoptosis : crosstalk with old and new pathways 187
Expression of Hes-1 (Notch-1 effector) during "In vitro" normal erythroid differentiation 186
Alu-dependent RNA editing of GLI1 promotes malignant regeneration in multiple myeloma 186
Hypoxia increases multiple myeloma stem cells by modulating notch signalling 185
Bone marrow-mediated drug resistance is promoted by Jagged-induced Notch signaling in multiple myeloma 185
AKT positively regulates Notch pathway in T-cell acute lymphoblastic leukemia 184
Jagged ligands enhance the pro-angiogenic activity of multiple myeloma cells 182
T-ALL leukemogenesis: involvement of Notch and ras pathway in the regulation of apoptosis and cell cycle 179
Notch targeting prevents multiple myeloma associated osteoclastogenesis 178
Regulation of the human glut4 gene expression in tumor RD18 cell line 175
PI3K/AKT signaling inhibits NOTCH1 lysosome-mediated degradation 174
No evidence for SEL1L as a candidate gene for IDDM11-conferred susceptibility 174
Notch controlla la comunicazione mediata dalle chemochine nel microambiente tumorale 173
Multiple myeloma-endothelium: 2D and 3D systems to study notch signaling 173
Multiple myeloma-associated drug resistance : targeting the Notch pathway 173
Notch1 oversignaling drives to deregulation of biological and molecular processes in T-ALL 172
Notch receptors regulate multiple myeloma-driven osteoclastogenesis 172
A novel therapeutic approach targeted notch in multiple myeloma based on small molecules uncoupling receptor-ligand interaction 171
Targeting the Notch pathway in multiple myeloma through small molecules uncoupling Notch-Jag interaction 170
Effects of motor deprivation on neurogenesis 170
Multiple myeloma related angiogenesis: role of notch signaling pathway 170
Cooperation between Notch and CXCR4/SDF1a axis in ovarian cancer 169
Notch signaling and multiple myeloma: challenging endogenous and bone marrow-mediated drug resistance 165
Jagged-induced notch signaling promotes endogenous and bone marrow-mediated drug resistance in multiple myeloma 162
Computer sequence analysis of highly conserved zinc fingers modules 160
MOTILITY AND INVASIVE PROPERTIES OF LAM/TSC CELLS FROM CHYLOUS OF A LAM/TSC PATIENT 160
Reduction of Movement in Neurological Diseases : Effects on Neural Stem Cells Characteristics 159
Notch Signal Transduction is not Regulated by Sel1L in Leukemia and Lymphoma Cells in culture. 158
Understanding the contribute of the notch pathway in multiple myeloma bone marrowniche : a focus on extracellular vesicles-mediated communicatio 158
Down-Regulation of Notch1 Expression is Involved in HL-60 Cell Growth Inhibition Induced by 4-Hydroxynonenal, a Product of Lipid Peroxidation 157
Burkitt lymphoma translocation turns Notch over to the dark side 156
A novel Notch-targeted therapeutic approach in multiple myeloma based on small molecules disrupting Notch-Jagged interaction 156
Targeting the interaction of multiple myeloma and the bone marrow microenvironment through novel small molecules directed to Notch pathway 156
Notch pathway promotes multiple myeloma cell IL-6 independence 155
Notch pathway and Inteleukin-6 cooperate to support multiple myeloma cell proliferation 154
Differential regulation of Notch signal transduction in leukemia and lymphoma cell in culture. 153
T-ALL leukemogenesis : which targets are modulated by Notch pathway to regulate apoptosis and cell cycle? 152
The effect of hypoxia on notch pathway in multiple myeloma niche 152
Understanding the interaction of human cancer cells with the surrounding microenvironment: the new challenge in modern oncology 151
Activation of long non-coding RNA NEAT1 leads to survival advantage of multiple myeloma cells by supporting a positive regulatory loop with DNA repair proteins 150
Chemokine receptors as novel targets of the oncogene Notch1 in acute lymphoblastic leukemia 149
Relationship of the oncogene Notch and CXCR4/SDF1 signaling in human epithelial ovarian cancer 148
Role of JAG1 and JAG2 ligands in promoting the angiogenic switch in multiple myeloma 148
Nanoplastics & health: taking a picture of bone cells 147
Produzione dell’omodimero (p40)2 dell’interleuchina 12 umana al fine di un’eventuale terapia immunologica nella sclerosi multipla 147
The notch ligands Jagged1 and 2 are a potential therapeutic target in multiple myeloma- associated bone disease 147
The Notch pathway controls multiple myeloma induced osteoclastogenesis 147
Promotion of human multiple myeloma cell growth in vitro and bone marrow invasion in vivo by Notch receptors and the CXCR4/SDF1 axis 146
Selective expression of the Sp17/AKAP4/PTTG1 in NSCLC for detection and therapy 146
Notch pathway and Interleukin-6 cooperate and support multiple myeloma cell growth 145
Lack of movement in neurological diseases : effects on neurogenesis and muscle-nerve interaction 144
Lung mesenchymal stem cells-derived extracellular vesicles attenuate the inflammatory profile of Cystic Fibrosis epithelial cells 142
Totale 20.338
Categoria #
all - tutte 70.674
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.674


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.168 0 0 0 0 0 0 0 0 373 506 162 127
2020/20212.662 179 186 145 161 190 214 158 192 521 172 396 148
2021/20222.938 241 117 194 177 157 218 234 191 296 253 432 428
2022/20232.489 259 213 287 208 361 455 47 167 291 38 117 46
2023/20243.927 66 111 137 185 489 119 518 413 244 437 577 631
2024/20254.251 566 726 455 751 436 242 237 517 321 0 0 0
Totale 26.664